EGD screening for Barrett's esophagus (BE) is costly, with insufficient evidence to support its effectiveness.
To compare acceptance and tolerability of 2 novel, office-based,… (More)
BACKGROUND & AIMS
Screening for Barrett's esophagus (BE) and esophageal adenocarcinoma is not recommended because it was not found to be cost effective. However, physician extenders (PEs) are able to… (More)